![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/07/shutterstock_1932094208-1.jpg)
AAIC 2024: the evolution of Alzheimer’s clinical trials
As the industry paints an increasingly clearer picture for Alzheimer’s disease pathologies, treatments are becoming more inclusive of non-pharmacological lifestyle changes, while clinical trials are moving towards optimised operations. Experts deliberated …